Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 1—January 2017
Dispatch

Acute Respiratory Disease in US Army Trainees 3 Years after Reintroduction of Adenovirus Vaccine1

Nakia S. Clemmons2Comments to Author , Zachary D. McCormic, Joel C. Gaydos, Anthony W. Hawksworth, and Nikki N. Jordan
Author affiliations: US Army Public Health Center, Aberdeen Proving Ground, Maryland, USA (N.S. Clemmons, Z.D. McCormic, J.C. Gaydos, N.N. Jordan); US Naval Health Research Center, San Diego, California, USA (A.W. Hawksworth)

Main Article

Figure 2

Adenovirus serotype distribution and acute respiratory disease (ARD) rate for all US Army initial entry training sites, by month, 2010–2014. ARD rate = (ARD cases/all trainees) × 100 trainee weeks.

Figure 2. Adenovirus serotype distribution and acute respiratory disease (ARD) rate for all US Army initial entry training sites, by month, 2010–2014. ARD rate = (ARD cases/all trainees) × 100 trainee weeks.

Main Article

1Preliminary results from this study were presented at the IDWeek 2014 meeting, October 8–12, 2014; Philadelphia, Pennsylvania, USA.

2Current affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Page created: December 14, 2016
Page updated: December 14, 2016
Page reviewed: December 14, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external